Production and characterization of a human antisperm monoclonal antibody against CD52g for topical contraception in women

BACKGROUND: Approximately 40% of human pregnancies are unintended, indicating a need for more acceptable effective contraception methods. New antibody production systems make it possible to manufacture reagent-grade human monoclonal antibodies (mAbs) for clinical use. We used the Nicotiana platform...

Descripción completa

Detalles Bibliográficos
Autores principales: Baldeon-Vaca, Gabriela, Marathe, Jai G., Politch, Joseph A., Mausser, Emilie, Pudney, Jeffrey, Doud, James, Nador, Ellena, Zeitlin, Larry, Pauly, Michael, Moench, Thomas R., Brennan, Miles, Whaley, Kevin J., Anderson, Deborah J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324805/
https://www.ncbi.nlm.nih.gov/pubmed/34256345
http://dx.doi.org/10.1016/j.ebiom.2021.103478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324805/
https://www.ncbi.nlm.nih.gov/pubmed/34256345
http://dx.doi.org/10.1016/j.ebiom.2021.103478

Ejemplares similares